| |
| |
|
Sub-Group: PHARMACY |
|
| |
|
|
|
| 1A |
|
PREPARATION, CHARACTERIZATION AND EVALUATION OF PGS-CELLULOSE CO-PROCESSED EXCIPIENT AS A NEW MATRIX FORMER FOR FLOATING TABLETS
K.P.R.Chowdary and D. Udaya chandra
|
|
| 2A |
|
INHIBITORY EFFECTS OF AQUEOUS PERICARP EXTRACT OF PUNICA GRANATUM ON IN VITRO PROTEIN GLYCOXIDATION
Swathi P, Kishore Naidu K and Eswar Kumar K |
|
| 3A |
|
ANTIHYPERGLYCEMIC ACTIVITY WITH DPP-IV INHIBITION OF PHYLLANTHUS EMBLICA L FRUIT EXTRACT IN ALLOXAN INDUCED DIABETIC RATS
Giri Babu. N, Priya Vadhana. S, Bhargavi. M and Eswar Kumar. K |
|
| 4A |
|
IN VITRO ANTIOXIDANT ACTIVITY AND IN VIVO HEPATOPROTECTIVE ACTIVITY OF AQUEOUS EXTRACT OF ALLIUM CEPA BULB IN ETHANOL INDUCED LIVER DAMAGE IN WISTAR RATS
G.V. Sampath Kumar, Sudheer V, Harsha KN and K. Eswar Kumar |
|
| 5A |
|
CURRENT AND FUTURE USE OF GENOMICS DATA IN TOXICOLOGY: OPPORTUNITIES AND CHALLENGES FOR REGULATORY APPLICATIONS
K.L.Naga Tulasi*, J.Shalini |
|
| 6A |
|
APPLICATION OF BIOINFORMATICS FOR DNA MICROARRAY DATA TO BIOSCIENCE, BIOENGINEERING AND MEDICAL FIELDS
J.Shalini*,K.L.Naga Tulasi. |
|
| 7A |
|
ADVANCING NON-VIRAL GENE DELIVERY -GEMINI SURFACTANT-BASED DELIVERY STRATEGIES
Martha Divya.A |
|
| 8A |
|
SYNTHESIS AND BIOCHEMICAL EVALUATION OF N-CINNAMOYL METFORMIN ANALOGUES
K. Bharathi and V. Anitha Kumari |
|
| 9A |
|
BIOINFORMATICS RESEARCH AND APPLICATIONS
G.Saritha, R.Sravya Krishna |
|
| 10A |
|
THE EMERGENCE OF HIV: A MOLECULAR ARCHEOLOGICAL APPROACH
R.Sravya Krishna, G.Saritha |
|
| 11A |
|
NEW DEVELOPMENTS IN THE MOLECULAR PHARMACOLOGY OF THE MYO-INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR
V.Sri Surya Prabha* and S. Krishna Veni |
|
| 12A |
|
GENE DELIVERY BY LIPOPLEXES AND POLYPLEXES
S. Krishna Veni * and V.Sri Surya Prabha |
|
| 13A |
|
PROMINENCE OF GENETIC VARIATIONS IN TAMOXIFEN METABOLIZING ENZYME CYP2D6 GENE IN THE BREAST CANCER PATIENTS
Shaik Nazia Tabassum, Mahesh Kandula, Kalyan Kumar CH |
|
| 14A |
|
AN INSIGHT OF GENOMICS – A MEDICAL PROSPECTIVE
Aashritha*, T.N.Varalakshmi, G.Sumalatha |
|
| 15A |
|
MOLECULAR GENETICS OF CORONARY ARTERY DISEASE
Khyrun baji*, B. Samuel Ignatious, Mr. P.Rama Krishna |
|
| 16A |
|
THE KEY ROLE OF GENOMICS IN MODERN VACCINE AND DRUG DESIGN FOR EMERGING INFECTIOUS DISEASES
N. Nuthana*, T.N.Varalakshmi, G.Sumalatha |
|
| 17A |
|
CLINICAL AND MOLECULAR GENETICS OF NEONATAL DIABETES DUE TO MUTATIONS IN THE INSULIN GENE
S. Sai Ramya*, B.S.K.Priya, P. Rama Krishna, G. Sumalatha |
|
| 18A |
|
NICOTINIC RECEPTORS IN ADDICTION PATHWAYS
K. Sreya*, T.N.Varalakshmi, G. Sumalatha |
|
| 19A |
|
DRUG TARGETING TO BRAIN
M.Priyanka |
|
| 20A |
|
PROTEINS AND PEPTIDES AS TARGETING CARRIERS IN ANTICANCER DRUG DELIVERY
R.Rani |
|
| 21A |
|
APTAMERS
D.Ashok*, P.N.V. Gopal |
|
| 22A |
|
CHEMICAL GENETICS: WHERE GENETICS AND PHARMACOLOGY MEET
K. Dilip Raja, S.A.Rahaman, CH.N.Kavitha |
|
| 23A |
|
CARBON NANOTUBES: THE FUTURE OF CANCER TREATMENT
P.Rani Soundarya |
|
| 24A |
|
THE POTENTIAL ROLE OF VILDAGLIPTIN IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS
V.L.Anusha*., B.Vidya Sagar |
|
| 25A |
|
PHARMACOGENOMICS OF PEDIATRIC ASTHAMA
G.Balaji, Kusuma. B |
|
| 26A |
|
CNS-ACTIVE DRUGS FROM PLANTS INDIGENOUS TO INDIA
B.Vidya Sagar, V.L.Anusha |
|
| 27A |
|
ROLE OF PHARMACOGENOMICS IN DRUG DISCOVERY AND DEVELOPMENT
CH.Hemalatha, T.Lakshmi Keerthy |
|
| 28A |
|
PROMISING MOLECULAR TARGETED THERAPIES IN BREAST CANCER
T.Lakshmi keerthy, CH. Hemalatha |
|
| 29A |
|
THERAPEUTIC ALTERNATIVES FROM VENOMS AND TOXINS
B.Kusuma, G.Balaji |
|
| 30A |
|
MOLECULAR GENETICS OF SCHIZOPHRENIA
A.Divya Sri, Sai Madhuri |
|
| 31A |
|
GENOMICS IN MEDICINE: GENETICS, INDIVIDUALITY AND MEDICINE
Vara Prasad Saka, S.A.Rahaman, CH.N.Kavitha |
|
| 32A |
|
ANTIMICROBIAL RESISTANCE: POTENTIAL THREAT AHEAD
D. G.V.S.Surya Chandini, V.Praveena |
|
| 33A |
|
TRANSFER FACTOR IN CANCER - CURRENT STATUS AND FUTURE PROSPECTS
Poojitha.M |
|
| 34A |
|
CANCER VACCINES
K.Hema Latha |
|
| 35A |
|
MONOCLONAL ANTIBODIES AS AGONISTS: AN EXPANDED ROLE IN CANCER THERAPY
Ch.Seilusha |
|
| 36A |
|
MONOCLONAL ANTIBODIES IN CANCER THERAPY
K.V.Sahithi |
|
| 37A |
|
RECENT ADVANCES IN PHARMACOGENOMICS ON RHEUMATOID ARTHRITIS
S.Teja sree |
|
| 38A |
|
PHARMACOGENETICS AND ITS APPLICATIONS
P.Sai Mounika |
|
| 39A |
|
CANCER PREVENTER AND TUMOR SUPPRESSOR-P53
G.Vijay Kumar*, N.Sumanth |
|
| 40A |
|
IMMUNOTHERAPY OF CANCER
M.Karthik siva kumar*, D.Pradeep |
|
| 41A |
|
GENE THERAPY – A Very Attractive Method for treating HIV
Veerendrateja*, Samuel Ignatious, P.N.V. Gopal |
|
| 42A |
|
DAWN OF POST ANTIBIOTIC AGE
Lakshmi Anusha*, P.N.V. Gopal |
|
| 43A |
|
STEM CELL THERAPY
K.Rajamohan reddy, J.Venkatesh |
|
| 44A |
|
EVALUATION OF ANTIOXIDANT, HYPOGLYCEMIC EFFECT AND ANTIHYPERGLYCEMIC EFFECT OF METHANOLIC PERICARP EXTRACT OF FERONIA LIMONIA IN NORMAL AND STREPTOZOTOCIN INDUCED DIABETIC RATS
Divya M, Swathi P and Eswar Kumar K |
|
| 45A |
|
EVALUATION OF ANTIOXIDANT, HYPOGLYCEMIC EFFECT AND ANTI HYPERGLYCEMIC EFFECT OF HYDRO ALCOHOLIC EXTRACT OF MOMORDICA COCHINCHINENESIS IN NORMAL AND STREPTOZOTOCIN INDUCED DIABETIC RATS
Hareesha M, Swathi P and K. Eswar Kumar |
|
| 46A |
|
MOLECULAR MECHANISM OF LIPID INDUCED INSULIN RESISTANCE
Naveen Krishna K, Sampat Kumar GV and Eswar Kumar K |
|
| 47A |
|
ANTI-HYPERGLYCEMIC AND RENO-PROTECTIVE ACTIVITIES OF AQUEOUS EXTRACT OF PUNICA GRANATUM IN STREPTAZOTOCIN INDUCED DIABETIC RATS
Santosh Kumar Ranajit, Ramya Krishna R, Swathi P and Eswar Kumar K |
|
| 48A |
|
THERAPEUTIC DRUG MONITORING OF FIRST LINE ANTI TUBERCULAR DRUGS IN PATIENTS WITH ACTIVE PULMONARY TUBERCULOSIS
Kishor Naidu K, Anusha T and K. Eswar Kumar |
|
| 49A |
|
EVALUATION OF ANTIHYPERGLYCEMIC ACTIVITY AND DIABETIC NEPHROPATHY OF AQUEOUS EXTRACT OF PHYLLANTHUS EMBLICA IN STREPTOZOTOCIN INDUCED DIABETIC RATS
Kotaiah S, Ramya Y, Swathi P and Eswar Kumar K |
|
| 50A |
|
INHIBITION OF DIPEPTIDYL PEPTIDASE-IV ACTIVITY BY PUNICA GRANATUM ENHANCES THE ANTIDIABETIC EFFECTS OF GLUCAGON-LIKE PEPTIDE-1
Bhargavi M, Priya Vadhana S, Giri Babu N and Eswar Kumar K |
|
| 51A |
|
MOLECULAR APPROACHES IN HIV DIAGNOSIS, TREATMENT AND DRUG DESIGN
T.K.N.V.Raja Kiranmai*, K . Anupama Priyadarshini. |
|
| 52A |
|
STEM CELL THERAPY
S.Raviteja*, Sri Devi.Buraga |
|
| 53A |
|
B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Lavanya Peyyala |
|
| 54A |
|
DESIGN AND CHARACTERIZATION OF HOLLOW/ POROUS FLOATING BEADS OF LISINOPRIL FOR PULSATILE DRUG DELIVERY
M.Veeranarayana* N.Venkateswarlu, G.V.Rami Reddy |
|
| 55A |
|
EVALUATION OF ANTI-INFLAMMATORY ACTIVITY
K.Rajesh*, T. Satyanrayana, K.Eswar kumar, N.Silvya |
|
| 56A |
|
FUNCTIONAL GENOMICS BY MASS SPECTROMETRY
Nambula Venkateswarlu, N. Delhiraj, Sreenu Thalla |
|
| 57A |
|
ROLE OF MOLECULAR GENETICS IN TRANSFORMING DIAGNOSIS OF DIABETES MELLITUS
P.Elisha Raju*, Ramesh, sreekanth Nama, Chandu baburao |
|
| 58A |
|
MOLECULAR GENETICS OF ALZHEIMER'S DISEASE
S.Sireesha*, B.Revathi, sreekanth Nama, Chandu baburao |
|
| 59A |
|
MOLECULAR APPROACHES FOR DIAGNOSIS OF HIV
S.Surekha*, B.Revathi, sreekanth Nama, Chandu baburao |
|
| 60A |
|
THE EVOLVING ROLE OF PHARMACOINFORMATICS AND THE INTERNET FOR CANCER THERAPY
V.Sarvani*, B.Revathi, sreekanth Nama, Chandu baburao |
|
| 61A |
|
SIMULTANEOUS ESTIMATION OF AMLODIPINE AND ATORVASTATIN IN TABLETS USING ORTHOGONAL FUNCTION RATIO SPECTROMETRY
B.Praveena*, S Manohar Babu, RG Tiruveedula |
|
| 62A |
|
SYNTHESIS OF HIGHLY POTENT NOVEL ANTI-TUBERCULAR ISONIAZID ANALOGUES WITH PRELIMINARY PHARMACOKINETIC EVALUATION
Sivaram Krishna* Venkatesh Jangala, AV Ramani |
|
| 63A |
|
APPLICATIONS OF BIO- PHARMACEUTICS
K.Nagakumari* , K.Vadivel, Manohar |
|
| 64A |
|
SUPER POROUS HYDROGELS
Shaik Reehana*., B.V.P.Deepthi |
|
| 65A |
|
EFFECT OF TELMISARTAN IN HIGH FRUCTOSE DIET INDUCED METABOLIC DYSFUNCTION IN RATS
M.Lalitha, R.Ramesh, G.Nagarjuna Reddy |
|
| 66A |
|
ANTI-DIABETIC AND ANTI-MICROBIAL ACTIVITY OF TECTONA GRANDIS EXTRACT AGAINST ALLOXAN-INDUCED DIABETIC RATS
G.Pradeep, V.Ramanarayana Reddy., G. Nagarjuna Reddy |
|
| 67A |
|
THE HUMAN GENOME PROJECT: DIVERGING PATHS, DIFFICULT CHOICES
Garnepudi Anusha*, Poonguzhali Sathish Kumar |
|
| 68A |
|
HEPATOPROTECTIVE EFFECT OF VITAMIN C
P.Kusumasai and Gnana Deep.G |
|
| 69A |
|
ANTIHYPERCHOLESTEROLEMIC EFFECT OF ECHINOCHLOA CRUSGALLI EXTRACT
D.Sathish Kumar, David Banji, A.Harani |
|
| |
|
|
|
| |
|
Sub-Group: MEDICAL |
|
| |
|
|
|
| 70A |
|
NEW CONCEPTS OF MOLECULAR PHARMACOLOGY
Zaheda bano |
|
| 71A |
|
GENETIC POLYMORPHISM: EFFECT ON HYPOLIPIDAEMIC DRUGS
Karuna Sree P*, Venkat Rao Y |
|
| 72A |
|
PHARMACOINFORMATICS
Ramya |
|
| 73A |
|
PHARMACOGENOMICS OF USING SULFONYLUREAS IN TYPE 2 DIABETICS
Manikanta.M, Manjunath.K, Venkata Rao.Y |
|
| 74A |
|
GENETIC PREDISPOSITION IN PARKINSON’S DISEASE: RESPONSE TO DOPAMINERGIC DRUGS
Kavitha.B, Venkata Rao.Y |
|
| 75A |
|
GENE POLYMORPHISMS IN ANTIHYPERTENSIVE DRUGS THAT MODIFY RENIN ANGIOTENSIN ALDOSTERONE SYSTEM (RAAS)
T.Krishnaveni, Venkata Rao.Y
|
|
| 76A |
|
PHARMCOGENOMIC APPROACH OF ANTI-PLATELET DRUGS - ASPIRIN AND CLOPIDOGREL
Roopa .B, Venkata Rao .Y |
|
| |
|
|
|
| |
|
Sub-Group: LIFE SCIENCES AND GENETICS |
|
| |
|
|
|
| 77A |
|
TNF Α AS A CANDIDATE GENE IN THE ETIOPATHOGENESIS OF POLYCYSTIC OVARIAN SYNDROME
Sujatha T, Kodati V, Jayashankar E, Anuradha K, Uma A, Q Hasan |
|
| 78A |
|
PHARMACEUTICAL BIOINFORMATICS: A NEW APPROACH FOR DRUG DISCOVERY
A. Krishna Satya*, K. Narendra, J. Swathi, K.M. Sowjanya |
|
| 79A |
|
MITOCHONDRIAL MEDIATED APOPTOTIC PATHWAY IN THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA
C.Anuradha, Sugunakar .Vuree, D.Nageswara Rao, D.Raghunadha Rao, S.Vishnupriya |
|
| 80A |
|
STUDIES ON BIOCHEMICAL DIAGNOSTIC INDICES AND MOLECULAR MARKER IN TYPE 2 DIABETES MELLITUS
M.Saraswati, G.Rajesh kumar, K.Mrudula spurthi, P.Chiranjeevi, G.Srilatha, G.Kishore Kumar, T.Mohini Aiyengar, D.Vijay shekar ReddY, H.surekha rani |
|
| 81A |
|
FUNCTIONAL POLYMORPHISM OF MATRIX METALLOPROTEINASE 9 AND LDL RECEPTOR EXPRESSION IN ATHEROSCLEROSIS
Mrudula Spurthi.K, Rajesh Kumar.G, Kishore Kumar.G, Sanjib Kumar.S, Prathiba.N, Surekha Rani.H |
|
| 82A |
|
STUDY ON MOMORDICA CHARANTIA FOR ITS HYPOGLYCEMIC ACTIVITY USING ALBINO WISTAR RATS
Jayasravanthi Mokkapati, Seenivasan, A. Krishna satya and M. Ramya prasanthi |
|
| 83A |
|
REVIEW ON ANTIMALARIAL DRUGS AND DRUG TARGETS
Seelam Jeevan Amos, Donepudi Siva Mallika, Kondapalli Kasturi*, Pavithra Venkateshaiah and KRS Sambasiva Rao |
|
| 84A |
|
PLANT BIOACTIVE COMPOUNDS AND THEIR ROLE IN DRUG DISCOVERY
K. Narendra, J. Swathi, K.M. Sowjanya, A. Krishna Satya |
|
| 85A |
|
PHARMACOLOGICAL PROFILE & MOLECULAR CHARACTERIZATION OF HERBAL PRODUCTS
K. M. Sowjanya, J. Swathi, K.Narendra, A. Krishna Satya |
|
| 86A |
|
MARINE ORGANISMS ARE FRUITFUL SOURCES FOR MOLECULAR PHARMACOLOGY
J.Swathi, K.M.Sowjnya, K.Narendra and A. Krishna Satya |
|
| 87A |
|
FAS GENE POLYMORPHISMS IN CHRONIC MYELOID LEUKEMIA
Prajitha.E.M, G.Manjula, K.Sailaja, D.Raghunadha Rao, S.Vishnupriya |
|
| 88A |
|
ANALYSIS OFATM GENE PROMOTER POLYMORPHISM IN CHRONIC MYELOID LEUKEMIA
G.Manjula, Prajitha E.M., K.Sailaja1, D.Raghunadha Rao1, S.Vishnupriya |
|
| 89A |
|
E-CADHERIN (-347 G/GA) PROMOTER POLYMORPHISM IN BREAST CANCER
N.Santhoshi Rani, D.Surekha, T.Nageswara Rao, Chiranjeevi Padala, Phanibhusan |
|
| 90A |
|
ASSOCIATION OF Sipa1 GENE (+545 C>T) POLYMORPHISM IN BREAST CANCER
Phanibhusan .M, N.Santhoshi Rani, D.Surekha, T.Nageswara Rao, Chiranjeevi.Padala, D. Raghunadha Rao, S.Vishnupriya. |
|
| 91A |
|
IMPACT OF STATIN THERAPY ON DNA DAMAGE IN MI PATIENTS
Kishore Kumar.G, Rajesh Kumar.G, Mrudula Spurthi.K, Sanjib Kumar.S |
|
| 92A |
|
IMMUNOINFLAMMATORY RESPONSES IN TYPE 2 DIABETIC NEPHROPATHY
Srilatha, Saraswati.M, Rajesh Kumar.G, Mrudula Spurthi, Swarnalatha.G, Surekha Rani.H |
|
| 93A |
|
SCREENING OF ANTIOXIDANT AND ANTI-MICROBIAL RESPONSES OF SOME MEDICINAL PLANTS GROWN IN WESTERN GHATS OF INDIA
N.Vijaya Sree, P.Udaya Sri, Y.V.V.Aswani Kumar and N.Rama Rao |
|
| 94A |
|
PATENT PROTECTION FOR STRUCTURAL GENOMICS RELATED INVENTIONS
R. Rajendar kumar and Syed Imtiaz ali |
|
